CTCFL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.330600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.653600E-01
Normal-vs-Stage2
2.732400E-01
Normal-vs-Stage3
2.740400E-01
Normal-vs-Stage4
6.842000E-01
Stage1-vs-Stage2
8.242600E-01
Stage1-vs-Stage3
7.256200E-01
Stage1-vs-Stage4
4.245200E-01
Stage2-vs-Stage3
5.740200E-01
Stage2-vs-Stage4
5.099200E-01
Stage3-vs-Stage4
3.586000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.627770E-01
Normal-vs-AfricanAmerican
9.266200E-01
Normal-vs-Asian
1.408020E-01
Caucasian-vs-AfricanAmerican
4.903000E-01
Caucasian-vs-Asian
3.324400E-01
AfricanAmerican-vs-Asian
3.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.968800E-01
Normal-vs-Female
2.989400E-01
Male-vs-Female
5.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.097200E-01
Normal-vs-Age(41-60Yrs)
3.099000E-01
Normal-vs-Age(61-80Yrs)
2.306800E-01
Normal-vs-Age(81-100Yrs)
1.845200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.929800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.099200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.178000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.503000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.141000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.120590E-01
Normal-vs-Daily Drinker
5.077600E-01
Normal-vs-Weekly Drinker
1.296150E-01
Normal-vs-Occasional Drinker
8.600600E-01
Normal-vs-Social Drinker
1.683150E-01
Non Drinker-vs-Daily Drinker
7.828800E-01
Non Drinker-vs-Weekly Drinker
6.284200E-01
Non Drinker-vs-Occasional Drinker
1.099160E-01
Non Drinker-vs-Social Drinker
9.370000E-01
Daily Drinker-vs-Weekly Drinker
5.868800E-01
Daily Drinker-vs-Occasional Drinker
3.122800E-01
Daily Drinker-vs-Social Drinker
8.333000E-01
Weekly Drinker-vs-Occasional Drinker
1.006780E-01
Weekly Drinker-vs-Social Drinker
6.386600E-01
Occasional Drinker-vs-Social Drinker
1.455360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.464620E-01
Normal-vs-Grade 2
1.419220E-01
Normal-vs-Grade 3
2.054000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.540700E-03
Grade 1-vs-Grade 3
1.299850E-03
Grade 1-vs-Grade 4
1.464620E-01
Grade 2-vs-Grade 3
6.603200E-01
Grade 2-vs-Grade 4
1.419220E-01
Grade 3-vs-Grade 4
2.054000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.228180E-01
Normal-vs-NonDiabetic
3.082000E-01
Diabetic-vs-NonDiabetic
4.731400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.257600E-01
Normal-vs-NoPancreatitis
1.631800E-01
Pancreatitis-vs-NoPancreatitis
3.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.143790E-01
Normal-vs-N1
3.045600E-01
N0-vs-N1
5.968800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.390600E-01
Normal-vs-TP53-NonMutant
1.204410E-01
TP53-Mutant-vs-TP53-NonMutant
3.588500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
